PITYRIASIS RUBRA PILARIS

This adverse event was reported 139 times

These drugs are most commonly taken by patients reporting PITYRIASIS RUBRA PILARIS:

# Drug Count
0 USTEKINUMAB 29
1 ACITRETIN 25
2 ADALIMUMAB 22
3 METHOTREXATE 19
4 METHOTREXATE SODIUM 19
5 INFLIXIMAB 11
6 PREDNISONE 10
7 VALACYCLOVIR HYDROCHLORIDE 10
8 MYCOPHENOLATE MOFETIL 9
9 DUPILUMAB 7
See all common drugs associated with PITYRIASIS RUBRA PILARIS

PITYRIASIS RUBRA PILARIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 GRISEOFULVIN 2 0.0086
1 PREDNICARBATE 1 0.0078
2 ACITRETIN 25 0.0078
3 DESOGESTREL/ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL 1 0.0015
4 IMIQUIMOD 3 0.0012
5 TAZAROTENE 1 0.0011
6 EPINASTINE HYDROCHLORIDE 1 0.0011
7 ALENDRONATE SODIUM AND CHOLECALCIFEROL 2 0.0007
8 RISANKIZUMAB-RZAA 6 0.0007
9 USTEKINUMAB 29 0.0004
See all drugs enriched for association with PITYRIASIS RUBRA PILARIS

PITYRIASIS RUBRA PILARIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Tubulin Inhibiting Agent [EPC] 2 0.0086
1 Interleukin-12 Antagonist [EPC] 29 0.0004
2 Interleukin-23 Antagonist [EPC] 31 0.0004
3 Vitamin D Analog [EPC] 1 0.0003
4 Antimalarial [EPC] 1 0.0002
5 Retinoid [EPC] 29 0.0001
6 Antiprotozoal [EPC] 1 0.0001
7 Lipopeptide Antibacterial [EPC] 1 0.0001
8 Calcineurin Inhibitor Immunosuppressant [EPC] 7 0.0001
9 Thrombopoietin Receptor Agonist [EPC] 1 0.0001
See all drug classes enriched for association with PITYRIASIS RUBRA PILARIS